Found: 21
Select item for more details and to access through your institution.
Regorafenib regressed a doxorubicin-resistant Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Potential drug-drug interactions and nephrotoxicity in hematopoietic stem cell transplant adult recipients during bone marrow transplantation unit stay.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pharmacokinetics, absorption, metabolism, and excretion of [<sup>14</sup>C]ivosidenib (AG-120) in healthy male subjects.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Gefitinib exposure and occurrence of interstitial lung disease in Japanese patients with non-small-cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
SCMCIE94: an intensified pilot treatment protocol known to be associated with cure in CD 56-negative non-pelvic isolated Ewing sarcoma (EWS) is also associated with no early relapses in non-metastatic extremity EWS.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A study of second-line irinotecan plus cisplatin vs. irinotecan alone in platinum-naïve patients with early relapse of gastric cancer refractory to adjuvant S-1 monotherapy: exploratory subgroup analysis of the randomized phase III TRICS trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Classification and regression tree-based prediction of 6-mercaptopurine-induced leucopenia grades in children with acute lymphoblastic leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety assessment of anticancer drugs in association with radiotherapy in metastatic malignant melanoma: a real-life report : Radiation/systemic drug combo in metastatic melanoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Irinotecan induces enterocyte cell death and changes to muc2 and muc4 composition during mucositis in a tumour-bearing DA rat model.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Determination of melphalan in human plasma by UPLC-UV method.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Disruption of CTLA-4 expression on peripheral blood CD8 + T cell enhances anti-tumor efficacy in bladder cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men.
- Published in:
- 2019
- By:
- Publication type:
- journal article
CDA and MTHFR polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine-based chemotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pharmacokinetics and safety of olaparib tablets as monotherapy and in combination with paclitaxel: results of a Phase I study in Chinese patients with advanced solid tumours.
- Published in:
- 2019
- By:
- Publication type:
- journal article
TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pazopanib interacts with irinotecan by inhibiting UGT1A1-mediated glucuronidation, but not OATP1B1-mediated hepatic uptake, of an active metabolite SN-38.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Eligibility criteria for phase I clinical trials: tight vs loose?
- Published in:
- 2019
- By:
- Publication type:
- journal article
The clinical added value of the addition of anti-CTL-4 to anti-PD-1 alone is questionable and clearly increasing toxicity regarding pivotal studies in the treatment of melanoma and renal carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- letter